Continuous Epidural Analgesia Versus Continuous Supra-Inguinal Fascia Iliaca Block in Total Hip Replacement Surgery

Comparison Of Continuous Epidural Analgesia And Ultrasound Guided Continuous Supra-Inguinal Fascia Iliaca Compartment Block After Total Hip Replacement Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04196439

Acronym

S-FICB

Enrollment

Registered

2019-12-12

Start date

2019-11-02

Completion date

2020-03-31

Last updated

2019-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

comparison of continuous epidural analgesia and ultrasound guided continuous supra-inguinal fascia iliaca compartment block after total hip replacement surgery

Detailed description

supra-inguinal FICB is a promising safe approach for lumbar plexus that may be useful for analgesia in hip surgeries.In this study the investigators are comparing continuous S-FICB with continuous epidural analgesia after total hip arthroplasty surgeries with the primary aim to assess efficacy of post-operative analgesia, and secondary aim to assess rehabilitation indices, side effects and radiological pattern of local anaesthetic distribution after S-FICB.

Interventions

PROCEDUREcontinuous epidural analgesia

injection of local anaesthetic into epidural space

PROCEDUREsupra-inguinal fascia iliaca compartment block

ultrasound guided injection of local anaesthetic into fascia iliaca compartment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* orthopaedic patients, American Society of Anesthesiologists (ASA) physical status I-III, scheduled to undergo unilateral total hip replacement surgery via lateral approach

Exclusion criteria

* 1- History of neurological/neuromuscular, psychiatric disease, dementia preventing proper comprehension. 2- Patients younger than 18 years or older than 80 years. 3- Patients with Body Mass Index (BMI) \<18.5 or \>30 kg/m2. 4- Coagulation disturbances (INR\>1.4, platelet count\<100 000). 5- History of opioid dependence (opioid use within the last 4 weeks). 6- History of allergies to study medications. 7- Other contraindications to neuraxial blockade (e.g., patient refusal, local/systemic sepsis, low fixed cardiac output). 8- Contraindications to continuous fascia iliaca compartment block (e.g., infection overlying the injection site or previous femoro-popliteal bypass surgery).

Design outcomes

Primary

Measure	Time frame	Description
postoperative analgesia after THA surgery	36 hours	visual analogue scale (VAS) scores for pain assessment at rest and movements and morphine consumption

Secondary

Measure	Time frame	Description
radiological pattern of local anaesthetic distribution in S-FICB group	30 minutes after local anaesthetic injection	imaging of pelvis using x-rays c arm machine
success of rehabilitation	36 hours	rehabilitation indices achievement after THA

Countries

Egypt

Contacts

Primary Contactahmad S alabd, master

ahmadsam23@gmail.com0020 1001643215

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026